These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 30881384)

  • 1. MicroRNAs in Alzheimer's Disease.
    Wang M; Qin L; Tang B
    Front Genet; 2019; 10():153. PubMed ID: 30881384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs as Therapeutic Tools in Alzheimer's Disease.
    Lee CY; Ryu IS; Ryu JH; Cho HJ
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
    Bowirrat A
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: presence and role of microRNAs.
    Basavaraju M; de Lencastre A
    Biomol Concepts; 2016 Aug; 7(4):241-52. PubMed ID: 27505094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the mechanisms of non-coding RNAs' implication in the pathogenesis of Alzheimer's disease.
    Khodayi-Shahrak M; Khalaj-Kondori M; Hosseinpour Feizi MA; Talebi M
    EXCLI J; 2022; 21():921-940. PubMed ID: 36110561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between long non-coding RNAs and Alzheimer's disease: a systematic review.
    Chen L; Guo X; Li Z; He Y
    Pathol Res Pract; 2019 Jan; 215(1):12-20. PubMed ID: 30470438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.
    Wong BX; Hung YH; Bush AI; Duce JA
    Front Aging Neurosci; 2014; 6():91. PubMed ID: 24860500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target.
    Zhang M; Bian Z
    Front Neurosci; 2021; 15():687973. PubMed ID: 34108863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as diagnostic and therapeutic tools for Alzheimer's disease: advances and limitations.
    Martinez B; Peplow PV
    Neural Regen Res; 2019 Feb; 14(2):242-255. PubMed ID: 30531004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Do Recent Clinical Trials Teach Us About the Etiology of AD.
    Robakis NK
    Adv Exp Med Biol; 2020; 1195():167. PubMed ID: 32468473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.
    Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN
    Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.
    Hadar A; Milanesi E; Squassina A; Niola P; Chillotti C; Pasmanik-Chor M; Yaron O; Martásek P; Rehavi M; Weissglas-Volkov D; Shomron N; Gozes I; Gurwitz D
    Transl Psychiatry; 2016 Oct; 6(10):e909. PubMed ID: 27701409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.